FindTrial
Sign In

Randomized Controlled Trial on the Efficacy and Safety of Acupuncture for Obstructive Sleep Apnea Hypopnea Syndrome

Randomized Controlled Trial on the Efficacy and Safety of Acupuncture for Obstructive Sleep Apnea Hypopnea Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000472
Enrollment
Unknown
Registered
2024-09-24
Start date
2024-07-24
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Hypopnea Syndrome

Interventions

Wait-list control group:None
Acupuncture group:Acupuncture

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1)Patients aged between 30 and 70 years old; (2)Diagnosed with obstructive sleep apnea hypopnea syndrome by PSG (Polysomnography); (3)Body Mass Index (BMI) =35; (4)Patients provide informed consent and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1)Long-term heavy alcohol consumption and/or use of sedative-hypnotic or muscle relaxant drugs such as Estazolam; (2)Presence of organic obstruction in the nasopharyngeal area or other organic diseases that can cause sleep apnea such as nasal polyps nasopharyngeal tumors deviated nasal septum turbinate hypertrophy grade II or higher tonsil hypertrophy etc.; (3)History of tracheal intubation or surgery or trauma to the oral cavity pharynx trachea or chest; (4)Currently using continuous positive airway pressure (CPAP) or having undergone oropharyngeal training within the last month; (5)Patients who have developed serious complications after onset such as severe cerebral edema brain herniation epilepsy hydrocephalus or those with severe heart disease lung disease malignant tumors or other major organ dysfunction; (6)Patients who have had a stroke or other complications requiring continuous hospitalization; (7)Pregnant women women planning to become pregnant or nursing mothers; (8)Patients who are currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
AHI;—

Secondary

MeasureTime frame
Mean Arterial Oxygen Saturation;Snoring Scale (SS);Self-Rating Depression Scale;Compliance Questionnaire;Epworth Sleepiness Scale (ESS);Oxygen Desaturation Index;Acupuncture Sensation Scale;(Fatigue Scale-14 FS-14);Self-Rating Anxiety Scale;-Longest Apnea Duration;Medical Outcomes Study 12-Item Short-Form Health Survey;LSaO2;Athens Insomnia Scale (AIS);—

Countries

China

Contacts

Public ContactXianggang Meng

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

sd_mxg@126.com15822832375

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026